STRATA Skin Sciences Inc (SSKN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, STRATA Skin Sciences Inc (SSKN) has a cash flow conversion efficiency ratio of -0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-64.00K) by net assets ($1.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
STRATA Skin Sciences Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how STRATA Skin Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read STRATA Skin Sciences Inc debt and liabilities for a breakdown of total debt and financial obligations.
STRATA Skin Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of STRATA Skin Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Real Good Food Company, Inc.
NYSE:RGFC
|
N/A |
|
The Pebble Group PLC
LSE:PEBB
|
-0.019x |
|
Iofina plc
LSE:IOF
|
0.034x |
|
HCW Biologics Inc
NASDAQ:HCWB
|
1.538x |
|
Wynnstay Group Plc
LSE:WYN
|
0.178x |
|
Lapidoth-Heletz Limited Partnership
TA:LPHL-L
|
-0.001x |
|
Nuwellis Inc
NASDAQ:NUWE
|
-0.804x |
|
FINEQIA INTERN. INC. O.N.
F:FNQA
|
0.125x |
Annual Cash Flow Conversion Efficiency for STRATA Skin Sciences Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of STRATA Skin Sciences Inc from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see STRATA Skin Sciences Inc (SSKN) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $4.97 Million | $188.00K | 0.038x | +192.44% |
| 2023-12-31 | $12.69 Million | $-519.00K | -0.041x | +19.41% |
| 2022-12-31 | $21.83 Million | $-1.11 Million | -0.051x | -185.53% |
| 2021-12-31 | $25.41 Million | $1.51 Million | 0.059x | -26.70% |
| 2020-12-31 | $25.89 Million | $2.10 Million | 0.081x | +4.06% |
| 2019-12-31 | $28.65 Million | $2.23 Million | 0.078x | -16.06% |
| 2018-12-31 | $31.25 Million | $2.90 Million | 0.093x | -50.20% |
| 2017-12-31 | $22.25 Million | $4.14 Million | 0.186x | +750.73% |
| 2016-12-31 | $14.72 Million | $322.00K | 0.022x | +105.34% |
| 2015-12-31 | $16.09 Million | $-6.58 Million | -0.409x | +71.62% |
| 2014-12-31 | $12.28 Million | $-17.71 Million | -1.443x | +38.35% |
| 2013-12-31 | $8.30 Million | $-19.41 Million | -2.340x | -70.12% |
| 2012-12-31 | $13.98 Million | $-19.22 Million | -1.376x | -134.86% |
| 2011-12-31 | $29.81 Million | $-17.46 Million | -0.586x | +1.04% |
| 2010-12-31 | $31.80 Million | $-18.82 Million | -0.592x | -3.70% |
| 2009-12-31 | $30.32 Million | $-17.30 Million | -0.571x | +46.85% |
| 2008-12-31 | $15.09 Million | $-16.20 Million | -1.074x | -101.89% |
| 2007-12-31 | $20.77 Million | $-11.05 Million | -0.532x | -11.79% |
| 2006-12-31 | $21.31 Million | $-10.14 Million | -0.476x | -48.05% |
| 2005-12-31 | $18.25 Million | $-5.87 Million | -0.321x | -137.23% |
| 2004-12-31 | $-3.55 Million | $-3.06 Million | 0.863x | -88.93% |
| 2003-12-31 | $-218.00K | $-1.70 Million | 7.798x | -- |
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC exc… Read more